CClinicalTrials.gg
CompletedNCT07399522Updated Feb 10, 2026

Home-Based Calligraphic Handwriting Exercises in Parkinson's Disease

An interventional study of Calligraphic Handwriting Exercise Program in PARKINSON DISEASE (Disorder), sponsored by Sara Llamas Velasco. Completed at 1 site in Spain. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by Sara Llamas Velasco · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Jul 2022, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
53
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

Parkinson's disease is a progressive neurodegenerative disorder with no curative treatment currently available. Its symptoms lead to increasing limitations in daily activities, with impairments in manual dexterity being particularly relevant. Handwriting difficulties are common in patients with Parkinson's disease; however, it remains unclear whether a rehabilitation program based on handwriting exercises can improve overall manual dexterity and daily functioning.

This randomized, single-blind controlled trial aims to evaluate the effects of a 12-week home-based calligraphic handwriting exercise program on manual dexterity in patients with Parkinson's disease. Participants will be recruited from the Movement Disorders Clinic of Hospital 12 de Octubre (Madrid, Spain) and randomly assigned to either an intervention group or a control group.

Manual dexterity will be primarily assessed using the Purdue Pegboard Test across scheduled study visits. Secondary outcomes will include measures of dexterity related to activities of daily living, quality of life, and motor function.

02

Conditions studied

  • PARKINSON DISEASE (Disorder)

Browse trials for

03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 53 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

This is the only study on the registry with Sara Llamas Velasco as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients aged 40 to 80 years
  • Clinical diagnosis of Parkinson's disease according to the UK Brain Bank criteria.
  • Hoehn and Yahr stage 1 to 4
  • Assessed in the ON-medication state (approximately 90 minutes after levodopa intake)
  • Stable antiparkinsonian treatment for at least 4 weeks prior to study entry and maintained throughout the study period

Exclusion criteria

EXCLUSION CRITERIA:

  • Parkinson's disease-related dementia, defined as a Montreal Cognitive Assessment (MoCA) score \< 21
  • Upper limb comorbidities unrelated to Parkinson's disease that could interfere ith exercise performance (e.g., arthritis, recent fractures, stroke sequelae, or peripheral neuropathy)
  • Severe tremor or severe dyskinesias affecting the dominant hand, defined as:

    • a score ≥ 3 on UPDRS-III items 20 or 22, or
    • score ≥ 2 on UPDRS-IV item 33
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
53 participants (actual)

Study arms

  • Experimental
    Calligraphic Handwriting Exercise Program

    Participants assigned to this group will perform a structured home-based calligraphic handwriting exercise program designed to improve fine motor control and manual dexterity over a 12-week period.

    Behavioral: Calligraphic Handwriting Exercise Program

  • No intervention
    Usual Care

    Participants assigned to this group will receive usual clinical care and will not participate in the calligraphic handwriting exercise program during the study period.

Interventions

  • BehavioralCalligraphic Handwriting Exercise Program

    A structured home-based calligraphic handwriting exercise program designed to train fine motor control and manual dexterity. Participants perform predefined handwriting exercises regularly over a 12-week period using provided written materials.

06

What researchers measure

Primary outcomes

  1. Change in Manual Dexterity

    Manual dexterity will be assessed using the Purdue Pegboard Test. The primary outcome will be the change in Purdue Pegboard Test score from baseline across scheduled study visits.

    Time frame: Baseline and up to 12 weeks

07

Study locations

1 site
  • Hospital Universitario 12 de Octubre
    Madrid, Madrid, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07399522
Lead sponsor
Sara Llamas Velasco
Collaborators
Carlos III Health Institute
Responsible party
Sara Llamas Velasco (Postdoctoral Researcher in Neurology, Hospital Universitario 12 de Octubre) — Sponsor-investigator
First posted
Feb 10, 2026
Start date
Jul 5, 2022
Primary completion
Sep 8, 2025
Completion
Sep 8, 2025
Last update
Feb 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion